Bio automation

Over 20 years of expertise in automation and precision dispensing

CUSTOMER CASE
Water quality analysis
Multiplex tests to detect pathogens and toxins in public water supply

“A key step on the preparation of the biochip is printing the microarray; here we can produce hundreds of small spots, less than a millimeter in diameter. The great advantage of this method is that we can get an answer almost immediately; in a day we can detect up to 150 different species in the water.”

 

Dr. Wilfried Weigel, VP of R&D at SCIENION

What is Bioautomation?

The Bioautomation business area serves customers in the life science and diagnostic industries with end to end products and services in precision dispensing, multiplex analysis, miniaturization and automation, enabling research-to-production scalability.

Application areas

Enabling rapid, low-cost and reliable quantification for point-of-care testing performed quickly by non-experts.
Scalable nanoliter volume library preparation of single cells for advanced single cell applications.
Revolutionizing the manufacturing of medical, diagnostic disposable and microfluidic devices.
Efficient, sensitive, robust, rapid and inexpensive tests to monitor water quality for control and prevention of diseases caused by waterborne pathogens and algal toxins.
CUSTOMER CASE
Water quality analysis
Multiplex tests to detect pathogens and toxins in public water supply

Monitoring the quality of water is of paramount importance for public health. SCIENION’s commitment to develop efficient, sensitive and robust multiplex tests for water quality analysis is reflected by the company’s involvement in various research projects such as microAQUA or “Rheines Wasser”.

In the EU-funded project microAQUA, twelve partners from eight countries collaborated to develop universal microarrays for the evaluation of fresh-water quality. MicroAQUA aimed to design and develop a microarray chip for the high-throughput detection of known and emerging pathogens (bacteria, viruses, protozoa and cyanobacteria) and to assess the water quality by monitoring the presence of select bioindicators such as diatoms.

The company developed the microarrays and provided the infrastructure and expertise for the production of the arrays and their analysis. This microarray was used for the analysis of the RNA extracted from environmental samples collected from fresh, brackish, marine and drinking water from different locations in six countries (Bulgaria, France, Germany, Ireland, Italy and Turkey).

In the EU-funded project microAQUA, twelve partners from eight countries collaborated to develop universal microarrays for the evaluation of fresh-water quality. MicroAQUA aimed to design and develop a microarray chip for the high-throughput detection of known and emerging pathogens (bacteria, viruses, protozoa and cyanobacteria) and to assess the water quality by monitoring the presence of select bioindicators such as diatoms.

 

The company developed the microarrays and provided the infrastructure and expertise for the production of the arrays and their analysis. This microarray was used for the analysis of the RNA extracted from environmental samples collected from fresh, brackish, marine and drinking water from different locations in six countries (Bulgaria, France, Germany, Ireland, Italy and Turkey).

 

Read more on scienion.com →

“A key step on the preparation of the biochip is printing the microarray; here we can produce hundreds of small spots, less than a millimeter in diameter. The great advantage of this method is that we can get an answer almost immediately; in a day we can detect up to 150 different species in the water.”

 

Dr. Wilfried Weigel, VP of R&D at SCIENION

Bioautomation companies

A global market leader in ultra-low volume precision dispensing and microarray as well as biosensor technologies. Customers in the entire life science sector benefit from an integrated product portfolio and services advancing cost-efficient multiplex analysis, miniaturization and automation – from early research to high throughput production.
Founded in 2016 in Lyon, France, as a spin-off company of SCIENION GmbH based in Berlin, Germany, Cellenion uses SCIENION’s high precision non-contact dispensing technologies and provides solutions for single cell analysis and cloning.
Revolutionizing the manufacturing of medical, diagnostic disposable and microfluidic devices Established in Oulu, Finland 2010, Ginolis is revolutionizing the manufacturing of medical, diagnostic disposable and microfluidic devices in co-operation with many of the world’s leading diagnostic companies.